Growth of alternative protein products is really only just getting started, and products derived from mycelium prove that these alternatives can have staying power.
Growth of alternative protein products is really only just getting started, and products derived from mycelium prove that these alternatives can have staying power.
Suppliers to the biopharmaceutical and life science industries are collaborating to jointly drive the go to market and scale-up of cultured meat based on their experience in areas such as bioprocess development, quality control and regulatory compliance.
Cargill is investing in ENOUGH’s most recent (Series C) growth funding campaign and has signed a commercial agreement to use and market its fermented protein.